LATE-BREAKING ABSTRACT: IL-5-induced airways eosinophilia as a negative regulator of TLR7 expression may impair the interferon response to rhinovirus in allergic airways

A. Collison, L. Hatchwell, J. Girkin, K. Parsons, J. Li, J. Zhang, S. Phipps, D. Knight, N. W Bartlett, S. L Johnston, P. S Foster, P. A. B Wark, J. Mattes (Newcastle, Brisbane, Australia; Changchun, China; London, United Kingdom)

Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Session: The future has started: emerging potentials for personalised asthma treatment
Session type: Oral Presentation
Number: 2912
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Collison, L. Hatchwell, J. Girkin, K. Parsons, J. Li, J. Zhang, S. Phipps, D. Knight, N. W Bartlett, S. L Johnston, P. S Foster, P. A. B Wark, J. Mattes (Newcastle, Brisbane, Australia; Changchun, China; London, United Kingdom). LATE-BREAKING ABSTRACT: IL-5-induced airways eosinophilia as a negative regulator of TLR7 expression may impair the interferon response to rhinovirus in allergic airways. Eur Respir J 2014; 44: Suppl. 58, 2912

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: p-STAT6 and PU.1 are involved in IL-9 production by Th9 cells during allergen-induced late phase airway inflammation in asthma patients
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014

LATE-BREAKING ABSTRACT: Airway recruitment and anti-viral function of dendritic cells in asthmatic patients during RV-16 infection
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016

Eosinophilic airway inflammation is associated with increased TLR2 and TLR4 expression in adult asthmatics
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014


LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013

LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma.
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014

IL-37 requires IL18Rα and SIGIRR to diminish experimental allergic airway inflammation in mice
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015

TLR 7/8 agonist resiquimod alleviates murine allergic asthma through IL-27 production and up regulation of B7-H1 on antigen presenting cells
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015

HMGB1 expression and function in the allergic airway immune response
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014

LATE-BREAKING ABSTRACT: Interleukin-33 augments rhinovirus-induced type 2 immune responses in people with asthma, but not in healthy donors
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015


LATE-BREAKING ABSTRACT: TSLP as a potent activator of Th2 response in obstructive lung diseases
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016


TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014

LATE-BREAKING ABSTRACT: Inhibition of TRPA1 reduces airway inflammation and airway hyper-responsiveness in a murine model of allergic rhinitis
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016


Aspirin hypersensitive and aspirin-tolerant eosinophilic asthma share common patern of inflammatory cells influx and lipid mediators in airways
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014

Beta2 adrenergic agonist attenuates house dust mite-induced allergic airway inflammation in mice
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014


Preventative administration of IL-27 improves airway inflammation of ovalbumin –induced asthma mice model via both STAT1 and GADD45γ/p38MAPK pathways
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016


The percentage of neutrophils expressing TLR4 in induced sputum decreases in asthma not eosinophilic
Source: Annual Congress 2013 –Asthma
Year: 2013


Upregulation of CCL5 production in the airway epithelium at the time of the viral infection
Source: International Congress 2016 – Airway response to infection
Year: 2016


Pim1 kinase affects allergic asthma in a HDM-driven mice model
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014

LSC 2014 abstract - RORgamma t-specific RNAi decreases allergic airway inflammation and airway hyperresponsiveness in a mouse model of neutrophilic asthma
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014

LATE-BREAKING ABSTRACT: Attenuation of allergen-induced asthmatic responses by inhaled GATA-3 specific DNAzyme
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014